Display options
Cite
Faam B, Ghaffari MA, Ghadiri A, et al. Epigenetic modifications in human thyroid cancer. Biomed Rep. 2014;3(1):3-8doi: 10.3892/br.2014.375.
Faam, B., Ghaffari, M. A., Ghadiri, A., & Azizi, F. (2015). Epigenetic modifications in human thyroid cancer. Biomedical reports, 3(1), 3-8. https://doi.org/10.3892/br.2014.375
Faam, Bita, et al. "Epigenetic modifications in human thyroid cancer." Biomedical reports vol. 3,1 (2015): 3-8. doi: https://doi.org/10.3892/br.2014.375
Faam B, Ghaffari MA, Ghadiri A, Azizi F. Epigenetic modifications in human thyroid cancer. Biomed Rep. 2015 Jan;3(1):3-8. doi: 10.3892/br.2014.375. Epub 2014 Nov 03. PMID: 25469237; PMCID: PMC4251143.
Copy Download .nbib Format: NLM
Share it on

Biomed Rep. 2015 Jan;3(1):3-8. doi: 10.3892/br.2014.375. Epub 2014 Nov 03.

Epigenetic modifications in human thyroid cancer.

Biomedical reports

Bita Faam, Mohammad Ali Ghaffari, Ata Ghadiri, Fereidoun Azizi

Affiliations

  1. Cellular and Molecular Research Center, Jundishapur University of Medical Sciences, Ahvaz, Tehran, Iran.
  2. Cellular and Molecular Research Center, Department of Biochemistry, School of Medicine, Tehran, Iran.
  3. Cellular and Molecular Research Center, Jundishapur University of Medical Sciences, Ahvaz, Tehran, Iran ; Department of Immunology, Faculty of Medicine, Jundishapur University of Medical Sciences, Ahvaz, Tehran, Iran.
  4. Endocrine Research Center, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 25469237 PMCID: PMC4251143 DOI: 10.3892/br.2014.375

Abstract

Thyroid carcinoma is the most common endocrine malignancy of the endocrine organs, and its incidence rate has steadily increased over the last decade. Over 95% of thyroid carcinoma is derived from follicular cells that have a spectrum of differentiation to the most invasive malignancy. The molecular pathogenesis of thyroid cancer remains to be clarified, although activating the

Keywords: DNA methylation; epigenetic; microRNA; thyroid cancer

References

  1. Clin Cancer Res. 2011 Jul 15;17(14):4772-81 - PubMed
  2. Thyroid. 2001 Jan;11(1):3-14 - PubMed
  3. Science. 2003 Apr 18;300(5618):455 - PubMed
  4. Indian J Hum Genet. 2012 Sep;18(3):340-3 - PubMed
  5. Langenbecks Arch Surg. 2010 Sep;395(7):877-83 - PubMed
  6. Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19075-80 - PubMed
  7. J Thyroid Res. 2011;2011:895470 - PubMed
  8. Cancer Control. 2006 Apr;13(2):119-28 - PubMed
  9. Thyroid. 2006 Jan;16(1):17-23 - PubMed
  10. Endocr Pathol. 2002 Spring;13(1):3-16 - PubMed
  11. Med J Malaysia. 2006 Dec;61(5):564-9 - PubMed
  12. Cancer Res. 2010 Feb 15;70(4):1389-97 - PubMed
  13. Int J Cancer. 2014 Jan 15;134(2):257-67 - PubMed
  14. Arch Pathol Lab Med. 2009 May;133(5):683-91 - PubMed
  15. Cell. 2007 Feb 23;128(4):683-92 - PubMed
  16. PLoS One. 2013 Nov 25;8(11):e80266 - PubMed
  17. Cancer Res. 2006 Jan 15;66(2):898-906 - PubMed
  18. FEBS Lett. 2001 Jan 26;489(1):59-66 - PubMed
  19. Endocr Relat Cancer. 2007 Sep;14(3):791-8 - PubMed
  20. Int J Cancer. 2006 Nov 15;119(10 ):2322-9 - PubMed
  21. Cancer Res. 2007 Jan 1;67(1):381-90 - PubMed
  22. Hormones (Athens). 2007 Apr-Jun;6(2):152-6 - PubMed
  23. Cancer Res. 2002 Jul 1;62(13):3698-701 - PubMed
  24. Cell Mol Life Sci. 2004 Dec;61(23):2924-31 - PubMed
  25. Carcinogenesis. 2010 Jan;31(1):27-36 - PubMed
  26. J Clin Endocrinol Metab. 2003 Jun;88(6):2745-52 - PubMed
  27. Nature. 2005 Jun 9;435(7043):834-8 - PubMed
  28. Endocr Relat Cancer. 2005 Jun;12(2):245-62 - PubMed
  29. J Clin Endocrinol Metab. 2009 Mar;94(3):1026-32 - PubMed
  30. J Clin Endocrinol Metab. 2005 Jul;90(7):4011-8 - PubMed
  31. Mol Cancer. 2007 Mar 13;6:21 - PubMed
  32. PLoS One. 2011 Feb 10;6(2):e16979 - PubMed
  33. Cancer Res. 2003 May 1;63(9):2316-21 - PubMed
  34. Endocrinology. 2007 Mar;148(3):948-53 - PubMed
  35. Mol Cell Biol. 2006 Mar;26(6):2130-45 - PubMed
  36. Lab Invest. 2009 Jul;89(7):791-9 - PubMed
  37. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5 - PubMed
  38. J Clin Endocrinol Metab. 2013 Jul;98(7):2811-21 - PubMed
  39. Oncogene. 2011 Jan 20;30(3):275-86 - PubMed
  40. Cancer Res. 2006 Aug 15;66(16):7880-8 - PubMed
  41. Gastroenterology. 2007 Aug;133(2):647-58 - PubMed
  42. Cancer Res. 2003 Apr 1;63(7):1454-7 - PubMed
  43. J Exp Clin Cancer Res. 2014 Jan 06;33:4 - PubMed
  44. Thyroid. 2012 Sep;22(9):890-6 - PubMed
  45. Med Sci Monit. 2004 Oct;10 (10 ):RA235-41 - PubMed
  46. Ann Med. 2014 Sep;46(6):397-408 - PubMed
  47. J Thyroid Res. 2011;2011:407123 - PubMed
  48. J Clin Endocrinol Metab. 2003 Nov;88(11):5399-404 - PubMed
  49. Nature. 2004 May 27;429(6990):457-63 - PubMed
  50. Nat Rev Cancer. 2006 Apr;6(4):292-306 - PubMed
  51. J Clin Endocrinol Metab. 2011 Mar;96(3):E546-53 - PubMed
  52. Gene. 2012 Apr 25;498(1):116-9 - PubMed
  53. Int J Endocrinol. 2013;2013:128735 - PubMed
  54. N Engl J Med. 2003 Nov 20;349(21):2042-54 - PubMed
  55. Oncogene. 2008 Apr 3;27(15):2128-36 - PubMed
  56. Science. 2001 Oct 26;294(5543):853-8 - PubMed
  57. J Thyroid Res. 2011;2011:264248 - PubMed
  58. Ann Clin Biochem. 2001 May;38(Pt 3):168-79 - PubMed
  59. Cancers (Basel). 2011 Jun 1;3(2):1732-43 - PubMed
  60. Am J Pathol. 2006 Feb;168(2):585-96 - PubMed
  61. Cancer Res. 2004 Mar 1;64(5):1664-8 - PubMed
  62. Mol Cell Biol. 2007 Oct;27(19):6647-58 - PubMed
  63. Biochemistry (Mosc). 2005 May;70(5):576-83 - PubMed
  64. Nat Med. 2003 Apr;9(4):407-15 - PubMed
  65. Oncogene. 2004 Feb 5;23(5):1117-24 - PubMed
  66. J Clin Endocrinol Metab. 2006 Sep;91(9):3584-91 - PubMed
  67. Pharmacol Ther. 2009 Jul;123(1):117-41 - PubMed
  68. Exp Mol Pathol. 2013 Aug;95(1):62-7 - PubMed

Publication Types